Basket (0)
Wishlist (0)
Your personal newsletter
__

 
Product details:
ISBN13:9783031633652
ISBN10:3031633652
Binding:Hardback
No. of pages:342 pages
Size:254x178 mm
Language:English
Illustrations: 2 Illustrations, black & white; 39 Illustrations, color
697
Category:

Acute Myeloid Leukemia in Children

Standard of Care and Future Perspectives
 
Edition number: 2024
Publisher: Springer
Date of Publication:
Number of Volumes: 1 pieces, Book
 
Normal price:
Publisher's listprice:
EUR 181.89
Estimated price in HUF:
75 056 HUF (71 482 HUF + 5% VAT)
Why estimated?
 
Your price:
69 052 (65 763 HUF + 5% VAT )
discount is: 8% (approx 6 004 HUF off)
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
 
Availability:
Not yet published.
 
Add to basket
  Piece(s)

 
Short description:

This book provides up-to-date information on key topics and issues in Pediatric Acute Myeloid Leukemia (AML), including the epidemiology, biology, diagnosis and treatment of particular forms of the disease, supportive care, and survivorship. The entire spectrum of clinical management on pediatric AML is covered with the aim of equipping readers with the latest knowledge relevant to clinical practice and research, based on enormous efforts made by cooperative clinical trial groups and consortia worldwide. Each chapter is written by internationally renowned authorities who have been selected for their expertise in the subjects discussed. This book will serve pediatric hematologists/oncologists, fellows, and residents both as a comprehensive source of information and as a quick reference. The book will also be of interest to pediatricians and general practitioners.

Long description:
This book provides up-to-date information on key topics and issues in Pediatric Acute Myeloid Leukemia (AML), including the epidemiology, biology, diagnosis and treatment of particular forms of the disease, supportive care, and survivorship. The entire spectrum of clinical management on pediatric AML is covered with the aim of equipping readers with the latest knowledge relevant to clinical practice and research, based on enormous efforts made by cooperative clinical trial groups and consortia worldwide. Each chapter is written by internationally renowned authorities who have been selected for their expertise in the subjects discussed. This book will serve pediatric hematologists/oncologists, fellows, and residents both as a comprehensive source of information and as a quick reference. The book will also be of interest to pediatricians and general practitioners.
Table of Contents:

 Part-1: Epidemiology and Biology of Pediatric AML. Overview and Epidemiology of Pediatric AML.-  Chromosomal and Genomic Alterations in Pediatric AML.-  Germline Predisposition of Pediatric AML. Part-2: Diagnosis of pediatric AML. Diagnosis and Classifications of Pediatric AML.-  Measurable Residual Disease Assessment in Pediatric AML. Part-3: Advances in Treatment of Pediatric AML. De Novo AML.-  Extramedullary AML (CNS disease. non-CNS extramedullary disease. and myeloid sarcoma).-  Acute Promyelocytic Leukemia.-  Myeloid Proliferations Associated with Down Syndrome (ML-DS. TAM).-  Myeloproliferative Disorders in Non-Down Syndrome Patients.-  AML in Specific Age Groups (Infants. Adolescents and Young Adults).-  Myeloid Neoplasms Post Cytotoxic Therapy in Children.-  Advanced MDS in Children.-  Relapsed/Refractory AML in Children and Evolution of Novel Therapies.-  Stem Cell Transplantation/Cellular and Immunotherapies.-  Pediatric AML in Resource-Limited Countries. Part-4: Supportive Issues in Pediatric AML. Infection Management in Pediatric AML.-  Cardiotoxicity in Pediatric AML.-  Late effects in Pediatric AML Survivors.